BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vijay-Kumar M, Wu H, Aitken J, Kolachala VL, Neish AS, Sitaraman SV, Gewirtz AT. Activation of toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm Bowel Dis. 2007;13:856-864. [PMID: 17393379 DOI: 10.1002/ibd.20142] [Cited by in Crossref: 101] [Cited by in F6Publishing: 104] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Liberti A, Zucchetti I, Melillo D, Skapura D, Shibata Y, De Santis R, Pinto MR, Litman GW, Dishaw LJ. Chitin protects the gut epithelial barrier in a protochordate model of DSS-induced colitis. Biol Open 2018;7:bio029355. [PMID: 29222175 DOI: 10.1242/bio.029355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 LeMessurier KS, Häcker H, Chi L, Tuomanen E, Redecke V. Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung. PLoS Pathog 2013;9:e1003727. [PMID: 24244159 DOI: 10.1371/journal.ppat.1003727] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 7.1] [Reference Citation Analysis]
3 Negi S, Das DK, Pahari S, Nadeem S, Agrewala JN. Potential Role of Gut Microbiota in Induction and Regulation of Innate Immune Memory. Front Immunol 2019;10:2441. [PMID: 31749793 DOI: 10.3389/fimmu.2019.02441] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 26.0] [Reference Citation Analysis]
4 Abe K, Nguyen KP, Fine SD, Mo JH, Shen C, Shenouda S, Corr M, Jung S, Lee J, Eckmann L. Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells. Proc Natl Acad Sci USA. 2007;104:17022-17027. [PMID: 17942668 DOI: 10.1073/pnas.0708469104] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 6.7] [Reference Citation Analysis]
5 Dubois H, van Loo G, Wullaert A. Nucleic Acid Induced Interferon and Inflammasome Responses in Regulating Host Defense to Gastrointestinal Viruses. Int Rev Cell Mol Biol 2019;345:137-71. [PMID: 30904192 DOI: 10.1016/bs.ircmb.2018.08.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
6 Zeiser R, Penack O, Holler E, Idzko M. Danger signals activating innate immunity in graft-versus-host disease. J Mol Med 2011;89:833-45. [DOI: 10.1007/s00109-011-0767-x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 7.0] [Reference Citation Analysis]
7 Ramnath D, Powell EE, Scholz GM, Sweet MJ. The toll-like receptor 3 pathway in homeostasis, responses to injury and wound repair. Semin Cell Dev Biol 2017;61:22-30. [PMID: 27552920 DOI: 10.1016/j.semcdb.2016.08.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
8 Sánchez de Medina F, Romero-Calvo I, Mascaraque C, Martínez-Augustin O. Intestinal inflammation and mucosal barrier function. Inflamm Bowel Dis. 2014;20:2394-2404. [PMID: 25222662 DOI: 10.1097/mib.0000000000000204] [Cited by in Crossref: 154] [Cited by in F6Publishing: 62] [Article Influence: 25.7] [Reference Citation Analysis]
9 Østvik AE, Granlund AV, Torp SH, Flatberg A, Beisvåg V, Waldum HL, Flo TH, Espevik T, Damås JK, Sandvik AK. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2. Clin Exp Immunol 2013;173:502-11. [PMID: 23668802 DOI: 10.1111/cei.12136] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
10 Ciorba MA, Bettonville EE, McDonald KG, Metz R, Prendergast GC, Newberry RD, Stenson WF. Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis. J Immunol 2010;184:3907-16. [PMID: 20181893 DOI: 10.4049/jimmunol.0900291] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 6.5] [Reference Citation Analysis]
11 Cai Y, Xu B, Zhou F, Wu J, Li S, Zheng Q, Li Y, Li X, Gao F, Dong S, Liu R. Si-Ni-San ameliorates chronic colitis by modulating type I interferons-mediated inflammation. Phytomedicine 2021;84:153495. [PMID: 33611210 DOI: 10.1016/j.phymed.2021.153495] [Reference Citation Analysis]
12 Carvalho FA, Nalbantoglu I, Aitken JD, Uchiyama R, Su Y, Doho GH, Vijay-Kumar M, Gewirtz AT. Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges. Mucosal Immunol 2012;5:288-98. [PMID: 22318495 DOI: 10.1038/mi.2012.8] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 8.8] [Reference Citation Analysis]
13 Gribar SC, Anand RJ, Sodhi CP, Hackam DJ. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J Leukoc Biol. 2008;83:493-498. [PMID: 18160540 DOI: 10.1189/jlb.0607358] [Cited by in Crossref: 130] [Cited by in F6Publishing: 119] [Article Influence: 9.3] [Reference Citation Analysis]
14 Morgan JLL, Ritchie LE, Crucian BE, Theriot C, Wu H, Sams C, Smith SM, Turner ND, Zwart SR. Increased dietary iron and radiation in rats promote oxidative stress, induce localized and systemic immune system responses, and alter colon mucosal environment. FASEB j 2013;28:1486-98. [DOI: 10.1096/fj.13-239418] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
15 van Vliet MJ, Harmsen HJ, de Bont ES, Tissing WJ. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 2010;6:e1000879. [PMID: 20523891 DOI: 10.1371/journal.ppat.1000879] [Cited by in Crossref: 225] [Cited by in F6Publishing: 193] [Article Influence: 20.5] [Reference Citation Analysis]
16 Tajima M, Wakita D, Noguchi D, Chamoto K, Yue Z, Fugo K, Ishigame H, Iwakura Y, Kitamura H, Nishimura T. IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells. J Exp Med. 2008;205:1019-1027. [PMID: 18426983 DOI: 10.1084/jem.20071133] [Cited by in Crossref: 124] [Cited by in F6Publishing: 119] [Article Influence: 9.5] [Reference Citation Analysis]
17 Cho H, Kelsall BL. The role of type I interferons in intestinal infection, homeostasis, and inflammation. Immunol Rev 2014;260:145-67. [PMID: 24942688 DOI: 10.1111/imr.12195] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
18 Ray A, Dittel BN. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis. Immunology 2015;146:359-68. [PMID: 26211540 DOI: 10.1111/imm.12511] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
19 Li Y, Handley SA, Baldridge MT. The dark side of the gut: Virome-host interactions in intestinal homeostasis and disease. J Exp Med 2021;218:e20201044. [PMID: 33760921 DOI: 10.1084/jem.20201044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sansonetti PJ. Host???bacteria homeostasis in the healthy and inflamed gut: . Current Opinion in Gastroenterology 2008;24:435-9. [DOI: 10.1097/mog.0b013e32830007f7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
21 Cole JE, Navin TJ, Cross AJ, Goddard ME, Alexopoulou L, Mitra AT, Davies AH, Flavell RA, Feldmann M, Monaco C. Unexpected protective role for Toll-like receptor 3 in the arterial wall. Proc Natl Acad Sci USA. 2011;108:2372-2377. [PMID: 21220319 DOI: 10.1073/pnas.1018515108] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 12.5] [Reference Citation Analysis]
22 Zhao HW, Yue YH, Han H, Chen XL, Lu YG, Zheng JM, Hou HT, Lang XM, He LL, Hu QL, Dun ZQ. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis. World J Gastroenterol 2017;23:999-1009. [PMID: 28246473 DOI: 10.3748/wjg.v23.i6.999] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
23 Fukata M, Abreu MT. Pathogen recognition receptors, cancer and inflammation in the gut. Curr Opin Pharmacol 2009;9:680-7. [PMID: 19828376 DOI: 10.1016/j.coph.2009.09.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
24 Kordjazy N, Haj-Mirzaian A, Haj-Mirzaian A, Rohani MM, Gelfand EW, Rezaei N, Abdolghaffari AH. Role of toll-like receptors in inflammatory bowel disease. Pharmacol Res 2018;129:204-15. [PMID: 29155256 DOI: 10.1016/j.phrs.2017.11.017] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
25 Günther C, Buchen B, Neurath MF, Becker C. Regulation and pathophysiological role of epithelial turnover in the gut. Seminars in Cell & Developmental Biology 2014;35:40-50. [DOI: 10.1016/j.semcdb.2014.06.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
26 Saha P, Chassaing B, Yeoh BS, Viennois E, Xiao X, Kennett MJ, Singh V, Vijay-Kumar M. Ectopic Expression of Innate Immune Protein, Lipocalin-2, in Lactococcus lactis Protects Against Gut and Environmental Stressors. Inflamm Bowel Dis 2017;23:1120-32. [PMID: 28445245 DOI: 10.1097/MIB.0000000000001134] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
27 Nasef NA, Ferguson LR. Inflammatory bowel disease and pregnancy: overlapping pathways. Transl Res. 2012;160:65-83. [PMID: 22687963 DOI: 10.1016/j.trsl.2011.12.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
28 Cromer WE, Mathis JM, Granger DN, Chaitanya GV, Alexander JS. Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol. 2011;17:578-593. [PMID: 21350707 DOI: 10.3748/wjg.v17.i5.578] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 81] [Article Influence: 8.9] [Reference Citation Analysis]
29 Srinivasan G, Aitken JD, Zhang B, Carvalho FA, Chassaing B, Shashidharamurthy R, Borregaard N, Jones DP, Gewirtz AT, Vijay-Kumar M. Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis. J Immunol 2012;189:1911-9. [PMID: 22786765 DOI: 10.4049/jimmunol.1200892] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 8.1] [Reference Citation Analysis]
30 Levin A, Shibolet O. Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory. World J Gastroenterol 2008;14:5149-53. [PMID: 18777591 DOI: 10.3748/wjg.14.5149] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
31 Metzger RN, Krug AB, Eisenächer K. Enteric Virome Sensing-Its Role in Intestinal Homeostasis and Immunity. Viruses 2018;10:E146. [PMID: 29570694 DOI: 10.3390/v10040146] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
32 Lagishetty V, Chun RF, Liu NQ, Lisse TS, Adams JS, Hewison M. 1-α-hydroxylase and innate immune responses to 25-hydroxyvitamin D in colonic cell lines. J Steroid Biochem Mol Biol. 2010;121:228-233. [PMID: 20152900 DOI: 10.1016/j.jsbmb.2010.02.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
33 Watanabe T, Asano N, Murray PJ, Ozato K, Tailor P, Fuss IJ, Kitani A, Strober W. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J Clin Invest 2008;118:545-59. [PMID: 18188453 DOI: 10.1172/JCI33145] [Cited by in Crossref: 35] [Cited by in F6Publishing: 142] [Article Influence: 2.7] [Reference Citation Analysis]
34 Corridoni D, Chapman T, Ambrose T, Simmons A. Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease. Front Med (Lausanne) 2018;5:32. [PMID: 29515999 DOI: 10.3389/fmed.2018.00032] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
35 Onyeagocha C, Hossain MS, Kumar A, Jones RM, Roback J, Gewirtz AT. Latent cytomegalovirus infection exacerbates experimental colitis. Am J Pathol. 2009;175:2034-2042. [PMID: 19815702 DOI: 10.2353/ajpath.2009.090471] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
36 Cario E. Therapeutic impact of toll-like receptors on inflammatory bowel diseases: A multiple-edged sword: . Inflammatory Bowel Diseases 2008;14:411-21. [DOI: 10.1002/ibd.20294] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
37 Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014;104:Unit 15.25. [PMID: 24510619 DOI: 10.1002/0471142735.im1525s104] [Cited by in Crossref: 531] [Cited by in F6Publishing: 467] [Article Influence: 75.9] [Reference Citation Analysis]
38 Lopetuso LR, Scaldaferri F, Pizarro TT. Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis. Fibrogenesis Tissue Repair 2012;5:18. [PMID: 23062310 DOI: 10.1186/1755-1536-5-18] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
39 Nakamura M, Funami K, Komori A, Yokoyama T, Aiba Y, Araki A, Takii Y, Ito M, Matsuyama M, Koyabu M. Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers. Hepatol Int. 2008;2:222-230. [PMID: 19669308 DOI: 10.1007/s12072-008-9055-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
40 Vijay-Kumar M, Aitken JD, Sanders CJ, Frias A, Sloane VM, Xu J, Neish AS, Rojas M, Gewirtz AT. Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J Immunol 2008;180:8280-5. [PMID: 18523294 DOI: 10.4049/jimmunol.180.12.8280] [Cited by in Crossref: 137] [Cited by in F6Publishing: 130] [Article Influence: 10.5] [Reference Citation Analysis]
41 Yang J, Kim M, Kim E, Cheon J, Lee Y, Kim Y, Lee S, Seo S, Shin S, Choi S, Kim B, Chang S, Ko H, Bae J, Kweon M. Enteric Viruses Ameliorate Gut Inflammation via Toll-like Receptor 3 and Toll-like Receptor 7-Mediated Interferon-β Production. Immunity 2016;44:889-900. [DOI: 10.1016/j.immuni.2016.03.009] [Cited by in Crossref: 108] [Cited by in F6Publishing: 87] [Article Influence: 21.6] [Reference Citation Analysis]
42 Maclachlan I. siRNAs with guts. Nat Biotechnol 2008;26:403-5. [PMID: 18392024 DOI: 10.1038/nbt0408-403] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
43 Lin Q, Li M, Fang D, Fang J, Su SB. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases. Int Immunopharmacol. 2011;11:1422-1432. [PMID: 21600309 DOI: 10.1016/j.intimp.2011.04.026] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
44 Kawashima T, Kosaka A, Yan H, Guo Z, Uchiyama R, Fukui R, Kaneko D, Kumagai Y, You DJ, Carreras J, Uematsu S, Jang MH, Takeuchi O, Kaisho T, Akira S, Miyake K, Tsutsui H, Saito T, Nishimura I, Tsuji NM. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-β. Immunity 2013;38:1187-97. [PMID: 23791646 DOI: 10.1016/j.immuni.2013.02.024] [Cited by in Crossref: 126] [Cited by in F6Publishing: 103] [Article Influence: 15.8] [Reference Citation Analysis]
45 Liu S, Zhang Y, Ren J, Li J. Microbial DNA Recognition by cGAS-STING and Other Sensors in Dendritic Cells in Inflammatory Bowel Diseases: . Inflammatory Bowel Diseases 2015;21:901-11. [DOI: 10.1097/mib.0000000000000299] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
46 McElrath C, Espinosa V, Lin JD, Peng J, Sridhar R, Dutta O, Tseng HC, Smirnov SV, Risman H, Sandoval MJ, Davra V, Chang YJ, Pollack BP, Birge RB, Galan M, Rivera A, Durbin JE, Kotenko SV. Critical role of interferons in gastrointestinal injury repair. Nat Commun 2021;12:2624. [PMID: 33976143 DOI: 10.1038/s41467-021-22928-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
47 Hirota SA, Ng J, Lueng A, Khajah M, Parhar K, Li Y, Lam V, Potentier MS, Ng K, Bawa M, McCafferty DM, Rioux KP, Ghosh S, Xavier RJ, Colgan SP, Tschopp J, Muruve D, MacDonald JA, Beck PL. NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis. 2011;17:1359-1372. [PMID: 20872834 DOI: 10.1002/ibd.21478] [Cited by in Crossref: 260] [Cited by in F6Publishing: 249] [Article Influence: 23.6] [Reference Citation Analysis]
48 Polak ME, Borthwick NJ, Gabriel FG, Jager MJ, Cree IA. Activation of tonsil dendritic cells with immuno-adjuvants. BMC Immunol 2008;9:10. [PMID: 18366670 DOI: 10.1186/1471-2172-9-10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
49 Ullah MO, Sweet MJ, Mansell A, Kellie S, Kobe B. TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target. J Leukoc Biol 2016;100:27-45. [PMID: 27162325 DOI: 10.1189/jlb.2RI1115-531R] [Cited by in Crossref: 72] [Cited by in F6Publishing: 32] [Article Influence: 14.4] [Reference Citation Analysis]
50 Chandrasekharan B, Bala V, Kolachala VL, Vijay-Kumar M, Jones D, Gewirtz AT, Sitaraman SV, Srinivasan S. Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis. PLoS One. 2008;3:e3304. [PMID: 18836554 DOI: 10.1371/journal.pone.0003304] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
51 Sasaki T, Nagashima H, Okuma A, Yamauchi T, Yamasaki K, Aiba S, So T, Ishii N, Owada Y, MaruYama T, Kobayashi S. Functional Analysis of the Transcriptional Regulator IκB-ζ in Intestinal Homeostasis. Dig Dis Sci 2021. [PMID: 33818662 DOI: 10.1007/s10620-021-06958-8] [Reference Citation Analysis]
52 Chiou YS, Ma NJ, Sang S, Ho CT, Wang YJ, Pan MH. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice. J Agric Food Chem. 2012;60:3441-3451. [PMID: 22409325 DOI: 10.1021/jf300441p] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
53 Brandl K, Beutler B. Creating diseases to understand what prevents them: genetic analysis of inflammation in the gastrointestinal tract. Curr Opin Immunol 2012;24:678-85. [PMID: 23123276 DOI: 10.1016/j.coi.2012.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
54 Cario E. Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction. Curr Opin Gastroenterol 2008;24:725-32. [PMID: 19122523 DOI: 10.1097/MOG.0b013e32830c4341] [Cited by in Crossref: 47] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
55 Moyano-Porcile V, Olavarría-Ramírez L, González-Arancibia C, Bravo JA, Julio-Pieper M. Short-term effects of Poly(I: C) on gut permeability. Pharmacol Res. 2015;101:130-136. [PMID: 26145280 DOI: 10.1016/j.phrs.2015.06.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
56 Sadik CD, Bachmann M, Pfeilschifter J, Mühl H. Activation of interferon regulatory factor-3 via toll-like receptor 3 and immunomodulatory functions detected in A549 lung epithelial cells exposed to misplaced U1-snRNA. Nucleic Acids Res 2009;37:5041-56. [PMID: 19541850 DOI: 10.1093/nar/gkp525] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
57 Mckay DM, Macnaughton WK. Mechanisms and Consequences of Intestinal Inflammation. Physiology of the Gastrointestinal Tract. Elsevier; 2012. pp. 2075-99. [DOI: 10.1016/b978-0-12-382026-6.00078-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 González-Navajas JM, Lee J, David M, Raz E. Immunomodulatory functions of type I interferons. Nat Rev Immunol. 2012;12:125-135. [PMID: 22222875 DOI: 10.1038/nri3133] [Cited by in Crossref: 633] [Cited by in F6Publishing: 564] [Article Influence: 70.3] [Reference Citation Analysis]
59 Alexander JS, Chaitanya GV, Grisham MB, Boktor M. Emerging roles of lymphatics in inflammatory bowel disease. Ann N Y Acad Sci. 2010;1207 Suppl 1:E75-E85. [PMID: 20961310 DOI: 10.1111/j.1749-6632.2010.05757.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
60 Lin Q, Fang D, Fang J, Ren X, Yang X, Wen F, Su SB. Impaired Wound Healing with Defective Expression of Chemokines and Recruitment of Myeloid Cells in TLR3-Deficient Mice. J I 2011;186:3710-7. [DOI: 10.4049/jimmunol.1003007] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
61 Yeoh BS, Aguilera Olvera R, Singh V, Xiao X, Kennett MJ, Joe B, Lambert JD, Vijay-Kumar M. Epigallocatechin-3-Gallate Inhibition of Myeloperoxidase and Its Counter-Regulation by Dietary Iron and Lipocalin 2 in Murine Model of Gut Inflammation. Am J Pathol. 2016;186:912-926. [PMID: 26968114 DOI: 10.1016/j.ajpath.2015.12.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
62 Penack O, Holler E, van den Brink MR. Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors. Blood. 2010;115:1865-1872. [PMID: 20042727 DOI: 10.1182/blood-2009-09-242784] [Cited by in Crossref: 113] [Cited by in F6Publishing: 98] [Article Influence: 9.4] [Reference Citation Analysis]
63 Sponheim J, Pollheimer J, Olsen T, Balogh J, Hammarström C, Loos T, Kasprzycka M, Sørensen DR, Nilsen HR, Küchler AM. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am J Pathol. 2010;177:2804-2815. [PMID: 21037074 DOI: 10.2353/ajpath.2010.100378] [Cited by in Crossref: 105] [Cited by in F6Publishing: 104] [Article Influence: 9.5] [Reference Citation Analysis]
64 Zheng B, Morgan ME, van de Kant HJ, Garssen J, Folkerts G, Kraneveld AD. Transcriptional modulation of pattern recognition receptors in acute colitis in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013;1832:2162-72. [DOI: 10.1016/j.bbadis.2013.07.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
65 Fraser-Pitt DJ, Cameron P, McNeilly TN, Boyd A, Manson EDT, Smith DGE. Phosphorylation of the epidermal growth factor receptor (EGFR) is essential for interleukin-8 release from intestinal epithelial cells in response to challenge with Escherichia coli O157 : H7 flagellin. Microbiology (Reading) 2011;157:2339-47. [PMID: 21546588 DOI: 10.1099/mic.0.047670-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
66 Bahrami F, Kukulski F, Lecka J, Tremblay A, Pelletier J, Rockenbach L, Sévigny J. Purine-metabolizing ectoenzymes control IL-8 production in human colon HT-29 cells. Mediators Inflamm 2014;2014:879895. [PMID: 25242873 DOI: 10.1155/2014/879895] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
67 López-Posadas R, Neurath MF, Atreya I. Molecular pathways driving disease-specific alterations of intestinal epithelial cells. Cell Mol Life Sci 2017;74:803-26. [PMID: 27624395 DOI: 10.1007/s00018-016-2363-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
68 Chassaing B, Srinivasan G, Delgado MA, Young AN, Gewirtz AT, Vijay-Kumar M. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One. 2012;7:e44328. [PMID: 22957064 DOI: 10.1371/journal.pone.0044328] [Cited by in Crossref: 260] [Cited by in F6Publishing: 237] [Article Influence: 28.9] [Reference Citation Analysis]
69 Hsieh H, Morin J, Filliettaz C, Varada R, Labarre S, Radi Z. Fecal Lipocalin-2 as a Sensitive and Noninvasive Biomarker in the TNBS Crohn’s Inflammatory Bowel Disease Model. Toxicol Pathol 2016;44:1084-94. [DOI: 10.1177/0192623316665927] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
70 Fukata M, Vamadevan AS, Abreu MT. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin Immunol. 2009;21:242-253. [PMID: 19748439 DOI: 10.1016/j.smim.2009.06.005] [Cited by in Crossref: 208] [Cited by in F6Publishing: 169] [Article Influence: 17.3] [Reference Citation Analysis]
71 Pryke KM, Abraham J, Sali TM, Gall BJ, Archer I, Liu A, Bambina S, Baird J, Gough M, Chakhtoura M, Haddad EK, Kirby IT, Nilsen A, Streblow DN, Hirsch AJ, Smith JL, DeFilippis VR. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. mBio 2017;8:e00452-17. [PMID: 28465426 DOI: 10.1128/mBio.00452-17] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
72 Cario E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis. 2010;16:1583-1597. [PMID: 20803699 DOI: 10.1002/ibd.21282] [Cited by in Crossref: 222] [Cited by in F6Publishing: 196] [Article Influence: 20.2] [Reference Citation Analysis]
73 Iizuka M, Konno S. Wound healing of intestinal epithelial cells. World J Gastroenterol. 2011;17:2161-2171. [PMID: 21633524 DOI: 10.3748/wjg.v17.i17.2161] [Cited by in CrossRef: 145] [Cited by in F6Publishing: 127] [Article Influence: 14.5] [Reference Citation Analysis]
74 Pimentel-Nunes P, Soares JB, Roncon-Albuquerque R, Dinis-Ribeiro M, Leite-Moreira AF. Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opin Ther Targets. 2010;14:347-368. [PMID: 20146632 DOI: 10.1517/14728221003642027] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
75 Lu P, Sodhi CP, Hackam DJ. Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis. Pathophysiology 2014;21:81-93. [PMID: 24365655 DOI: 10.1016/j.pathophys.2013.11.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 7.5] [Reference Citation Analysis]
76 Ocampo SM, Romero C, Aviñó A, Burgueño J, Gassull MA, Bermúdez J, Eritja R, Fernandez E, Perales JC. Functionally enhanced siRNA targeting TNFα attenuates DSS-induced colitis and TLR-mediated immunostimulation in mice. Mol Ther 2012;20:382-90. [PMID: 22044934 DOI: 10.1038/mt.2011.236] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
77 Radulovic K, Manta C, Rossini V, Holzmann K, Kestler HA, Wegenka UM, Nakayama T, Niess JH. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential. J Immunol 2012;188:2001-13. [PMID: 22250092 DOI: 10.4049/jimmunol.1100765] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
78 Daoud F, Holmberg J, Alajbegovic A, Grossi M, Rippe C, Swärd K, Albinsson S. Inducible Deletion of YAP and TAZ in Adult Mouse Smooth Muscle Causes Rapid and Lethal Colonic Pseudo-Obstruction. Cell Mol Gastroenterol Hepatol 2021;11:623-37. [PMID: 32992050 DOI: 10.1016/j.jcmgh.2020.09.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Liu Y, Mo CF, Luo XY, Li H, Guo HJ, Sun H, Hu S, Li LM, Wang YT, Yang SX, Chang S, Zou Q. Activation of Toll-Like Receptor 3 Induces Interleukin-1 Receptor Antagonist Expression by Activating the Interferon Regulatory Factor 3. J Innate Immun 2020;12:304-20. [PMID: 31865314 DOI: 10.1159/000504321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Tang Y, Wu Y, Huang Z, Dong W, Deng Y, Wang F, Li M, Yuan J. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats. Nutrition 2017;33:96-104. [PMID: 27427511 DOI: 10.1016/j.nut.2016.05.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 8.4] [Reference Citation Analysis]
81 Drobny A, Ngo PA, Neurath MF, Zunke F, López-Posadas R. Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson's Disease. Front Med (Lausanne) 2021;8:655123. [PMID: 34368179 DOI: 10.3389/fmed.2021.655123] [Reference Citation Analysis]
82 Yeretssian G, Correa RG, Doiron K, Fitzgerald P, Dillon CP, Green DR, Reed JC, Saleh M. Non-apoptotic role of BID in inflammation and innate immunity. Nature 2011;474:96-9. [PMID: 21552281 DOI: 10.1038/nature09982] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 8.0] [Reference Citation Analysis]
83 Gribar SC, Richardson WM, Sodhi CP, Hackam DJ. No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol Med 2008;14:645-59. [PMID: 18584047 DOI: 10.2119/2008-00035.Gribar] [Cited by in Crossref: 117] [Cited by in F6Publishing: 61] [Article Influence: 9.0] [Reference Citation Analysis]
84 Achek A, Yesudhas D, Choi S. Toll-like receptors: promising therapeutic targets for inflammatory diseases. Arch Pharm Res 2016;39:1032-49. [PMID: 27515048 DOI: 10.1007/s12272-016-0806-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 13.0] [Reference Citation Analysis]
85 Chassaing B, Miles-Brown J, Pellizzon M, Ulman E, Ricci M, Zhang L, Patterson AD, Vijay-Kumar M, Gewirtz AT. Lack of soluble fiber drives diet-induced adiposity in mice. Am J Physiol Gastrointest Liver Physiol 2015;309:G528-41. [PMID: 26185332 DOI: 10.1152/ajpgi.00172.2015] [Cited by in Crossref: 91] [Cited by in F6Publishing: 81] [Article Influence: 15.2] [Reference Citation Analysis]
86 Yamashita M, Chattopadhyay S, Fensterl V, Zhang Y, Sen GC. A TRIF-independent branch of TLR3 signaling. J Immunol 2012;188:2825-33. [PMID: 22323545 DOI: 10.4049/jimmunol.1103220] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
87 Li JY, Xiao J, Gao M, Zhou HF, Fan H, Sun F, Cui DD. IRF/Type I IFN signaling serves as a valuable therapeutic target in the pathogenesis of inflammatory bowel disease. Int Immunopharmacol 2021;92:107350. [PMID: 33444921 DOI: 10.1016/j.intimp.2020.107350] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Fukata M, Arditi M. The role of pattern recognition receptors in intestinal inflammation. Mucosal Immunol. 2013;6:451-463. [PMID: 23515136 DOI: 10.1038/mi.2013.13] [Cited by in Crossref: 107] [Cited by in F6Publishing: 94] [Article Influence: 13.4] [Reference Citation Analysis]
89 Ta A, Thakur BK, Dutta P, Sinha R, Koley H, Das S. Double-stranded RNA induces cathelicidin expression in the intestinal epithelial cells through phosphatidylinositol 3-kinase-protein kinase Cζ-Sp1 pathway and ameliorates shigellosis in mice. Cellular Signalling 2017;35:140-53. [DOI: 10.1016/j.cellsig.2017.03.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
90 Avula LR, Knapen D, Buckinx R, Vergauwen L, Adriaensen D, Van Nassauw L, Timmermans JP. Whole-genome microarray analysis and functional characterization reveal distinct gene expression profiles and patterns in two mouse models of ileal inflammation. BMC Genomics 2012;13:377. [PMID: 22866923 DOI: 10.1186/1471-2164-13-377] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
91 Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol. 2008;43:1-17. [PMID: 18297430 DOI: 10.1007/s00535-007-2111-3] [Cited by in Crossref: 116] [Cited by in F6Publishing: 109] [Article Influence: 8.9] [Reference Citation Analysis]
92 Singh V, Yeoh BS, Chassaing B, Zhang B, Saha P, Xiao X, Awasthi D, Shashidharamurthy R, Dikshit M, Gewirtz A, Vijay-Kumar M. Microbiota-inducible Innate Immune, Siderophore Binding Protein Lipocalin 2 is Critical for Intestinal Homeostasis. Cell Mol Gastroenterol Hepatol 2016;2:482-498.e6. [PMID: 27458605 DOI: 10.1016/j.jcmgh.2016.03.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 9.6] [Reference Citation Analysis]
93 Ritchie LE, Taddeo SS, Weeks BR, Lima F, Bloomfield SA, Azcarate-Peril MA, Zwart SR, Smith SM, Turner ND. Space Environmental Factor Impacts upon Murine Colon Microbiota and Mucosal Homeostasis. PLoS One 2015;10:e0125792. [PMID: 26083373 DOI: 10.1371/journal.pone.0125792] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
94 Won HY, Lee JY, Ryu D, Kim HT, Chang SY. The Role of Plasmacytoid Dendritic Cells in Gut Health. Immune Netw 2019;19:e6. [PMID: 30838161 DOI: 10.4110/in.2019.19.e6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
95 Seo SU, Kweon MN. Virome-host interactions in intestinal health and disease. Curr Opin Virol 2019;37:63-71. [PMID: 31295677 DOI: 10.1016/j.coviro.2019.06.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
96 McAlpine W, Sun L, Wang KW, Liu A, Jain R, San Miguel M, Wang J, Zhang Z, Hayse B, McAlpine SG, Choi JH, Zhong X, Ludwig S, Russell J, Zhan X, Choi M, Li X, Tang M, Moresco EMY, Beutler B, Turer E. Excessive endosomal TLR signaling causes inflammatory disease in mice with defective SMCR8-WDR41-C9ORF72 complex function. Proc Natl Acad Sci U S A 2018;115:E11523-31. [PMID: 30442666 DOI: 10.1073/pnas.1814753115] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
97 Kotredes KP, Thomas B, Gamero AM. The Protective Role of Type I Interferons in the Gastrointestinal Tract. Front Immunol 2017;8:410. [PMID: 28428788 DOI: 10.3389/fimmu.2017.00410] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
98 van Lierop PP, Samsom JN, Escher JC, Nieuwenhuis EE. Role of the innate immune system in the pathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009;48:142-151. [PMID: 19179875 DOI: 10.1097/mpg.0b013e3181821964] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
99 Rose WA 2nd. Sakamoto K, Leifer CA. Multifunctional role of dextran sulfate sodium for in vivo modeling of intestinal diseases. BMC Immunol. 2012;13:41. [PMID: 22853702 DOI: 10.1186/1471-2172-13-41] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
100 Chattopadhyay S, Sen GC. dsRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effects. J Interferon Cytokine Res 2014;34:427-36. [PMID: 24905199 DOI: 10.1089/jir.2014.0034] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 10.7] [Reference Citation Analysis]
101 Walsh D, McCarthy J, O'Driscoll C, Melgar S. Pattern recognition receptors--molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine Growth Factor Rev 2013;24:91-104. [PMID: 23102645 DOI: 10.1016/j.cytogfr.2012.09.003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 7.2] [Reference Citation Analysis]
102 Neil JA, Matsuzawa-Ishimoto Y, Kernbauer-Hölzl E, Schuster SL, Sota S, Venzon M, Dallari S, Galvao Neto A, Hine A, Hudesman D, Loke P, Nice TJ, Cadwell K. IFN-I and IL-22 mediate protective effects of intestinal viral infection. Nat Microbiol 2019;4:1737-49. [PMID: 31182797 DOI: 10.1038/s41564-019-0470-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 16.0] [Reference Citation Analysis]
103 Srinivasan M, Summerlin D. Modulation of the colonic epithelial cell responses and amelioration of inflammation by CD80 blockade in TNBS colitis. Clinical Immunology 2009;133:411-21. [DOI: 10.1016/j.clim.2009.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
104 Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010;10:131-44. [PMID: 20098461 DOI: 10.1038/nri2707] [Cited by in Crossref: 783] [Cited by in F6Publishing: 696] [Article Influence: 71.2] [Reference Citation Analysis]